{"title":"Chronic Care Management: An Emerging Opportunity for Pharmacists.","authors":"Cody Clifton, Andrea Phillips, Amina Abubakar","doi":"10.4140/TCP.n.2018.611.","DOIUrl":"https://doi.org/10.4140/TCP.n.2018.611.","url":null,"abstract":"<p><p>Chronic care management (CCM) aims to improve health outcomes by enhancing care coordination for patients with multiple chronic conditions. However, few incentives have been provided in recent years for health care professionals to engage in models that improve care coordination. These potential models could help avoid poor health outcomes that lead to hospitalizations and rehospitalizations. Fortunately, in January 2015, under Medicare's physician fee schedule, Medicare began paying separately for CCM services. Qualified health care providers are reimbursed for these coordination of care services. Though pharmacists cannot bill Medicare for these services, they are in a prime position to deliver CCM services and be paid by forming contractual and collaborative partnerships with qualified providers. CCM bridges the gap between fee-for-service and value-based payment models by focusing on care coordination among health care providers.</p>","PeriodicalId":45985,"journal":{"name":"CONSULTANT PHARMACIST","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36701407","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Bianca F Nieves-Pérez, Sullynette Guerrero-De Hostos, Mariela I Frontera-Hernández, Iadelisse Cruz González, José Josué Hernández Muñoz
{"title":"Potentially Inappropriate Medication Use Among Institutionalized Older Adults at Nursing Homes in Puerto Rico.","authors":"Bianca F Nieves-Pérez, Sullynette Guerrero-De Hostos, Mariela I Frontera-Hernández, Iadelisse Cruz González, José Josué Hernández Muñoz","doi":"10.4140/TCP.n.2018.619.","DOIUrl":"https://doi.org/10.4140/TCP.n.2018.619.","url":null,"abstract":"<p><p><b>OBJECTIVES:</b> Prevalence of potentially inappropriate medications (PIMs) and potential prescribing omissions (PPOs). <b>DESIGN:</b> Cross-sectional study through review of residents' records. <b>SETTING:</b> Three nursing homes of Puerto Rico's metropolitan area. <b>PARTICIPANTS:</b> Nursing home residents. <b>INTERVENTION:</b> Records of residents 65 years of age and older with documented medications and chronic diseases were reviewed. Hospitalized and hospice/palliative care residents were excluded. Beers criteria-2015 and START-STOPP criteria-2014 were applied to identify PIMs and PPOs. Beers criteria versus STOPP criteria findings were compared. <b>MAIN OUTCOME MEASURE:</b> Prevalence of PIMs and PPOs in relation to residents' baseline characteristics. <b>RESULTS:</b> One hundred four records were reviewed. Categorical variables were analyzed by Fisher's exact test and chi square test; <i>t</i>-tests established a relationship between variables and the prevalence of PIMs and PPOs. The quantity of PIMs was analyzed through frequency and percentage values. A statistically significant correlation was found between prescribed medications and PIMs detected using Beers criteria (<i>P</i>-value = 0.031) and STOPP modified criteria (<i>P</i>-value = 0.0002). No statistically significant data were obtained from the START criteria. <b>CONCLUSION:</b> Beers criteria were more effective identifying PIMs compared with STOPP criteria. The number of prescribed medications correlated directly to the number of identified PIMs. Additional studies where these tools are applied, and clinical pharmacist interventions are performed, should confirm an improved management of nursing home residents' drug therapy in Puerto Rico.</p>","PeriodicalId":45985,"journal":{"name":"CONSULTANT PHARMACIST","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36701408","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Deprescribing in Primary Care in Singapore: Barriers and Facilitators.","authors":"Hui Shan Chia, Esther Siew Joo Bek","doi":"10.4140/TCP.n.2018.637.","DOIUrl":"https://doi.org/10.4140/TCP.n.2018.637.","url":null,"abstract":"<p><p><b>OBJECTIVES:</b> To describe the prevalence of potentially inappropriate medications (PIMs) in older patients (65 years of age and older) in three selected polyclinics (PCs) and gather the perceptions of the health care providers in these PCs on the barriers and facilitators of deprescribing in their practice. To analyze the patients' age, number of active chronic diseases, and number of medicines, and investigate if they could influence the presence of PIMs. <b>DESIGN:</b> The study has two separate parts: The first part is a retrospective cross-sectional data collection of prescriptions; the second part is a prospective cross-sectional analysis of questionnaires by health care providers. <b>SETTING:</b> The study is in an institutional primary care setting. <b>PATIENTS, PARTICIPANTS:</b> Prescriptions were from 210 randomly selected patients 65 years of age or older with at least five long-term medications, who had attended the PCs over a selected 10-day period. Health care providers from the PCs were surveyed via an anonymous questionnaire. <b>RESULTS:</b> The prevalence of PIMs is 44% of the prescriptions. The most prevalent PIM is \"long-term proton pump inhibitor (PPI) without documented indication\" at 45.7%. The number of active chronic diseases and total number of medications are associated with prevalence of PIMs. Facilitators and barriers of deprescribing highlighted are motivation and goals of the health care providers, knowledge, lack of time for deprescribing, and communication between specialists and primary care providers. <b>CONCLUSION:</b> PPI is a feasible drug class to start deprescribing in primary care. Knowing the barriers and facilitators would set the impetus for future work to make deprescribing more widespread and acceptable for primary care in Singapore.</p>","PeriodicalId":45985,"journal":{"name":"CONSULTANT PHARMACIST","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36701409","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Match Made in Heaven.","authors":"H Edward Davidson","doi":"10.4140/TCP.n.2018.605.","DOIUrl":"https://doi.org/10.4140/TCP.n.2018.605.","url":null,"abstract":"In this age of modern era, the use of internet must be maximized. Yeah, internet will help us very much not only for important thing but also for daily activities. Many people now, from any level can use internet. The sources of internet connection can also be enjoyed in many places. As one of the benefits is to get the on-line match made in heaven book, as the world window, as many people suggest.","PeriodicalId":45985,"journal":{"name":"CONSULTANT PHARMACIST","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36750894","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Sumaya Ased, Jana Wells, Lee E Morrow, Mark A Malesker
{"title":"Clinically Significant Food-Drug Interactions.","authors":"Sumaya Ased, Jana Wells, Lee E Morrow, Mark A Malesker","doi":"10.4140/TCP.n.2018.649.","DOIUrl":"https://doi.org/10.4140/TCP.n.2018.649.","url":null,"abstract":"<p><p><b>OBJECTIVE:</b> Provide an up-to-date review for health care providers regarding clinically significant food-drug interactions and summarize recommendations for optimal medication administration in older adults and long-term care patients. <b>DATA SOURCES:</b> A literature search was performed using MEDLINE, PUBMED, and IPA abstracts to locate relevant articles published between January 1982 and July 2017. DAILYMED was used to identify manufacturer-specific medication administration recommendations. <b>STUDY SELECTION AND DATA EXTRACTION:</b> Articles were reviewed for inclusion based on their relevance to this subject matter and the integrity of the information provided. Additionally, the package labeling of included products was reviewed. <b>DATA SYNTHESIS:</b> The current recommendations for specific medication administration with regard to food are summarized descriptively. <b>CONCLUSION:</b> Clinically significant food-drug interactions are common and have been reported with multiple classes of medications. However, there are a limited number of studies examining food-drug interactions, and the majority of recommendations are made by product-specific manufacturers. Pharmacists should be aware of common food-drug interactions in the community, assisted living, long-term care, subacute care, and hospital settings. To optimize medication therapy and improve therapeutic outcomes, it is important for pharmacists and other health care providers to identify agents with potential for food-drug interactions and to understand the clinical relevance of such interactions.</p>","PeriodicalId":45985,"journal":{"name":"CONSULTANT PHARMACIST","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36701410","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Slowly Connecting the Dots.","authors":"H Edward Davidson","doi":"10.4140/TCP.n.2018.533.","DOIUrl":"https://doi.org/10.4140/TCP.n.2018.533.","url":null,"abstract":"","PeriodicalId":45985,"journal":{"name":"CONSULTANT PHARMACIST","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36586667","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Lisa Morris, Stephanie Tsouvalas Hernandez, Deborah Milito, Greg Milanich, Jason Sutton, Terri Fagan
{"title":"New Members of the ASCP Board of Directors 2018-2019.","authors":"Lisa Morris, Stephanie Tsouvalas Hernandez, Deborah Milito, Greg Milanich, Jason Sutton, Terri Fagan","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":45985,"journal":{"name":"CONSULTANT PHARMACIST","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36586669","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Mary Geitona, Dimitra Latsou, Aikaterini Toska, Maria Saridi
{"title":"Polypharmacy and Adherence Among Diabetic Patients in Greece.","authors":"Mary Geitona, Dimitra Latsou, Aikaterini Toska, Maria Saridi","doi":"10.4140/TCP.n.2018.562.","DOIUrl":"https://doi.org/10.4140/TCP.n.2018.562.","url":null,"abstract":"<p><p><b>Introduction</b> Elderly patients are particularly susceptible to polypharmacy issues because of age-related changes in pharmacokinetics and pharmacodynamics as well as to chronic diseases resulting in a continuous increasing demand for drugs. <b>Objective</b> This study captures the prevalence of polypharmacy and adherence in Greece and identifies related risk factors in adult patients with diabetes. <b>Design</b> A cross-sectional study was conducted among patients diagnosed with diabetes mellitus attending public and private outpatients' clinics in the regions of Attica and Western Greece. <b>Results</b> A total of 644 outpatients filled out the questionnaire (relative risk = 91.7%). As far as the medications were concerned, 47.8% of patients had been receiving antidiabetic medication monotherapy, 38.2% combination therapy with two antidiabetic drugs, 11.8% with three drugs, and 2.2% with four drugs. The vast majority of diabetic patients adhered to their medication regimen, and fewer adhered to their physician's diet and physical activity recommendations. Statistically significant differences were found between age group and the existence of polypharmacy (P = 0.005). Additionally, 44.4% of patients with comorbidities exhibited polypharmacy, compared with 4.8% of patients who were diagnosed only with diabetes (P = 0.001). <b>Conclusion</b> The development of new strategies and health policies is necessary for polypharmacy and adherence among diabetic patients to be limited.</p>","PeriodicalId":45985,"journal":{"name":"CONSULTANT PHARMACIST","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36586672","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Daniel Z Mansour, Joseph G Marek, Rachelle Shelly Spiro, Nicole J Brandt
{"title":"How Consultant Pharmacists Gained Access to Maryland's Health Information Exchange.","authors":"Daniel Z Mansour, Joseph G Marek, Rachelle Shelly Spiro, Nicole J Brandt","doi":"10.4140/TCP.n.2018.547.","DOIUrl":"https://doi.org/10.4140/TCP.n.2018.547.","url":null,"abstract":"<p><p>The Chesapeake Regional Information System for our Patients (CRISP) is a health information exchange in Maryland that is designed to improve communication among members of the health care team including physicians, nurses, and other health professionals. Senior care pharmacists gained access to CRISP through successful collaborative efforts at both the state and national levels. This involved efforts to address medication-related problems that continue to be a concern during transitions of care, especially for older, vulnerable adults. Having access to recent clinical data assists the senior care pharmacist in providing medication therapy management services during transitions of care-the movement of a patient from one setting of care to another.This article highlights the importance of collaboration and advocacy between state and national leadership of the American Society of Consultant Pharmacists (ASCP) with key stakeholders to negotiate and gain access to such information for senior care pharmacists working in the post-acute and long-term care settings in Maryland.</p>","PeriodicalId":45985,"journal":{"name":"CONSULTANT PHARMACIST","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36586670","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}